CN107043378A - 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体 - Google Patents

一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体 Download PDF

Info

Publication number
CN107043378A
CN107043378A CN201610082028.3A CN201610082028A CN107043378A CN 107043378 A CN107043378 A CN 107043378A CN 201610082028 A CN201610082028 A CN 201610082028A CN 107043378 A CN107043378 A CN 107043378A
Authority
CN
China
Prior art keywords
compound
formula
preparation
independently selected
heterocycloalkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610082028.3A
Other languages
English (en)
Chinese (zh)
Inventor
丁照中
孙飞
胡迎虎
周义龙
赵锐
杨玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority to CN201610082028.3A priority Critical patent/CN107043378A/zh
Priority to TW106103696A priority patent/TW201728590A/zh
Priority to PCT/CN2017/072893 priority patent/WO2017133686A1/zh
Priority to NZ744885A priority patent/NZ744885A/en
Priority to CN201780009748.XA priority patent/CN108602832B/zh
Priority to EA201891769A priority patent/EA034581B1/ru
Priority to MYPI2018702701A priority patent/MY190551A/en
Priority to LTEP17747006.9T priority patent/LT3412673T/lt
Priority to AU2017214134A priority patent/AU2017214134B2/en
Priority to KR1020187024628A priority patent/KR102371500B1/ko
Priority to BR112018015879-8A priority patent/BR112018015879B1/pt
Priority to UAA201809087A priority patent/UA124100C2/uk
Priority to SI201730605T priority patent/SI3412673T1/sl
Priority to HUE17747006A priority patent/HUE053455T2/hu
Priority to PT177470069T priority patent/PT3412673T/pt
Priority to PL17747006T priority patent/PL3412673T3/pl
Priority to DK17747006.9T priority patent/DK3412673T3/da
Priority to EP17747006.9A priority patent/EP3412673B1/en
Priority to HRP20210103TT priority patent/HRP20210103T1/hr
Priority to SG11201806685VA priority patent/SG11201806685VA/en
Priority to US16/075,300 priority patent/US10654856B2/en
Priority to ES17747006T priority patent/ES2852323T3/es
Priority to HK19101234.3A priority patent/HK1259183B/zh
Priority to JP2018540720A priority patent/JP6877449B2/ja
Priority to CA3013520A priority patent/CA3013520C/en
Priority to MX2018009502A priority patent/MX374298B/es
Priority to ARP170100298A priority patent/AR107549A1/es
Publication of CN107043378A publication Critical patent/CN107043378A/zh
Priority to PH12018501642A priority patent/PH12018501642B1/en
Priority to CL2018002094A priority patent/CL2018002094A1/es
Priority to IL260999A priority patent/IL260999B/en
Priority to US16/847,394 priority patent/US20200239484A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CN201610082028.3A 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体 Pending CN107043378A (zh)

Priority Applications (31)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
TW106103696A TW201728590A (zh) 2016-02-05 2017-02-03 吡咯并[3,2-d]嘧啶類化合物的製備方法及其中間體
PL17747006T PL3412673T3 (pl) 2016-02-05 2017-02-04 Sposób otrzymywania związku pirolo[3,2-d]pirymidynowego i jego produktów pośrednich
DK17747006.9T DK3412673T3 (da) 2016-02-05 2017-02-04 Fremgangsmåde til fremstilling af pyrrolo[3,2-D]pyrimidin-forbindelse og mellemprodukter deraf
CN201780009748.XA CN108602832B (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
EA201891769A EA034581B1 (ru) 2016-02-05 2017-02-04 Способ получения соединения пирроло[3,2-d]пиримидина и промежуточных соединений
MYPI2018702701A MY190551A (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
LTEP17747006.9T LT3412673T (lt) 2016-02-05 2017-02-04 Pirolo[3,2-d]pirimidino junginio gamybos būdas ir jo tarpiniai junginiai
AU2017214134A AU2017214134B2 (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
KR1020187024628A KR102371500B1 (ko) 2016-02-05 2017-02-04 피롤로[3,2-d]피리미딘 화합물의 제조 방법, 및 이의 중간체
BR112018015879-8A BR112018015879B1 (pt) 2016-02-05 2017-02-04 Processo para preparação de pirrol[3,2-d]pirimidina, e seus intermediários composto, composição farmacêutica e usos de compostos
UAA201809087A UA124100C2 (uk) 2016-02-05 2017-02-04 Спосіб одержання сполуки піроло[3,2-d]піримідину і проміжних сполук
SI201730605T SI3412673T1 (sl) 2016-02-05 2017-02-04 Postopek za pripravo pirolo(3,2-d)pirimidinske spojine in njenih intermediatov
HUE17747006A HUE053455T2 (hu) 2016-02-05 2017-02-04 Eljárás pirrolo[3,2-D]pirimidin vegyület elõállítására és intermedierjei
PT177470069T PT3412673T (pt) 2016-02-05 2017-02-04 Método para preparar composto de pirrolo[3,2-d]pirimidina, e intermediários dos mesmos
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
EP17747006.9A EP3412673B1 (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
US16/075,300 US10654856B2 (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-D]pyrimidine compound, and intermediates thereof
NZ744885A NZ744885A (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
SG11201806685VA SG11201806685VA (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
HRP20210103TT HRP20210103T1 (hr) 2016-02-05 2017-02-04 Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera
ES17747006T ES2852323T3 (es) 2016-02-05 2017-02-04 Método de preparación del compuesto pirrolo[3,2-d]pirimidina e intermedios del mismo
HK19101234.3A HK1259183B (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
JP2018540720A JP6877449B2 (ja) 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体
CA3013520A CA3013520C (en) 2016-02-05 2017-02-04 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
MX2018009502A MX374298B (es) 2016-02-05 2017-02-04 Método para preparar compuesto de pirrolo[3,2-d]pirimidina y sus intermediarios.
ARP170100298A AR107549A1 (es) 2016-02-05 2017-02-06 Un proceso para preparar compuesto de pirrolo[3,2-d]pirimidina y su intermediario
PH12018501642A PH12018501642B1 (en) 2016-02-05 2018-08-02 Method for preparing pyrrolo[3,2-d]pyrimidine compound, and intermediates thereof
CL2018002094A CL2018002094A1 (es) 2016-02-05 2018-08-03 Un proceso para preparar compuesto de pirrolo[3,2–d]pirimidina y su intermediario
IL260999A IL260999B (en) 2016-02-05 2018-08-05 A method for the preparation of a pyrrolo[3,2-d] pyrimidine compound, and its intermediates
US16/847,394 US20200239484A1 (en) 2016-02-05 2020-04-13 Method for preparing pyrrolo[3,2,-d]pyrimidine compound, and intermediates thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (1)

Publication Number Publication Date
CN107043378A true CN107043378A (zh) 2017-08-15

Family

ID=59500148

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201610082028.3A Pending CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
CN201780009748.XA Active CN108602832B (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201780009748.XA Active CN108602832B (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Country Status (28)

Country Link
US (2) US10654856B2 (https=)
EP (1) EP3412673B1 (https=)
JP (1) JP6877449B2 (https=)
KR (1) KR102371500B1 (https=)
CN (2) CN107043378A (https=)
AR (1) AR107549A1 (https=)
AU (1) AU2017214134B2 (https=)
BR (1) BR112018015879B1 (https=)
CA (1) CA3013520C (https=)
CL (1) CL2018002094A1 (https=)
DK (1) DK3412673T3 (https=)
EA (1) EA034581B1 (https=)
ES (1) ES2852323T3 (https=)
HR (1) HRP20210103T1 (https=)
HU (1) HUE053455T2 (https=)
IL (1) IL260999B (https=)
LT (1) LT3412673T (https=)
MX (1) MX374298B (https=)
MY (1) MY190551A (https=)
NZ (1) NZ744885A (https=)
PH (1) PH12018501642B1 (https=)
PL (1) PL3412673T3 (https=)
PT (1) PT3412673T (https=)
SG (1) SG11201806685VA (https=)
SI (1) SI3412673T1 (https=)
TW (1) TW201728590A (https=)
UA (1) UA124100C2 (https=)
WO (1) WO2017133686A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107043380A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
MA44007A (fr) 2016-02-05 2018-12-19 Denali Therapeutics Inc Inhibiteurs du récepteur interagissant avec protéine kinase 1
JP7287708B2 (ja) 2019-02-08 2023-06-06 プロジェニア インコーポレイテッド Toll-like受容体7または8アゴニストとコレステロールの結合体およびその用途
JP7811014B2 (ja) 2020-03-02 2026-02-04 プロジェニア インコーポレイテッド 病原菌外壁成分基盤の生病原体模倣ナノ粒子及びその製造方法
CN116322751A (zh) 2020-08-04 2023-06-23 蛋白科技先锋 包含能够动力学控制的佐剂的mRNA疫苗
JP2023536954A (ja) 2020-08-04 2023-08-30 プロジェニア インコーポレイテッド 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途
US20230355750A1 (en) 2020-08-04 2023-11-09 Progeneer Inc. Kinetically acting adjuvant ensemble
IL314082A (en) 2022-01-12 2024-09-01 Denali Therapeutics Inc Crystal forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido[3,2-b][1,4]oxazapin-3-yl)- H4- 1,2,4-triazole-3-carboxamide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) * 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
ES2467108T3 (es) 2008-12-09 2014-06-11 Gilead Sciences, Inc. Moduladores de receptores tipo toll
LT2906563T (lt) * 2012-10-10 2018-06-11 Janssen Sciences Ireland Uc Pirolo[3,2-d]pirimidino dariniai virusinių infekcijų ir kitų ligų gydymui
MX358025B (es) * 2012-11-20 2018-08-02 Glaxosmithkline Llc Star Compuestos novedosos.
US9550785B2 (en) * 2012-11-20 2017-01-24 Glaxosmithkline Llc Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
JP6484253B2 (ja) * 2014-05-01 2019-03-13 ノバルティス アーゲー Toll様受容体7アゴニストとしての化合物および組成物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
HUE054672T2 (hu) 2014-08-15 2021-09-28 Chia Tai Tianqing Pharmaceutical Group Co Ltd TLR7 agonistaként alkalmazott pirrolopirimidin vegyületek
CA3004173C (en) 2015-11-05 2020-07-14 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 7-(thiazol-5-yl)pyrrolopyrimidine compound as tlr7 agonist
CN107043379A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途

Also Published As

Publication number Publication date
BR112018015879A2 (pt) 2018-12-26
MX2018009502A (es) 2018-12-11
PH12018501642A1 (en) 2019-06-03
HRP20210103T1 (hr) 2021-03-05
TW201728590A (zh) 2017-08-16
EP3412673A1 (en) 2018-12-12
WO2017133686A1 (zh) 2017-08-10
NZ744885A (en) 2022-07-01
US20190040072A1 (en) 2019-02-07
KR102371500B1 (ko) 2022-03-07
EA201891769A1 (ru) 2019-04-30
ES2852323T3 (es) 2021-09-13
CL2018002094A1 (es) 2018-12-07
AR107549A1 (es) 2018-05-09
MX374298B (es) 2025-03-06
CA3013520A1 (en) 2017-08-10
LT3412673T (lt) 2021-03-10
AU2017214134A1 (en) 2018-08-23
JP6877449B2 (ja) 2021-05-26
CN108602832A (zh) 2018-09-28
HUE053455T2 (hu) 2021-06-28
PT3412673T (pt) 2021-02-15
SG11201806685VA (en) 2018-09-27
PH12018501642B1 (en) 2019-06-03
UA124100C2 (uk) 2021-07-21
KR20180104724A (ko) 2018-09-21
US20200239484A1 (en) 2020-07-30
US10654856B2 (en) 2020-05-19
CA3013520C (en) 2022-07-19
EA034581B1 (ru) 2020-02-21
PL3412673T3 (pl) 2021-07-26
HK1259183A1 (zh) 2019-11-29
IL260999B (en) 2021-02-28
SI3412673T1 (sl) 2021-04-30
JP2019505531A (ja) 2019-02-28
BR112018015879B1 (pt) 2024-02-15
DK3412673T3 (da) 2021-01-18
AU2017214134B2 (en) 2020-08-27
EP3412673B1 (en) 2020-11-25
CN108602832B (zh) 2020-10-09
EP3412673A4 (en) 2019-07-03
MY190551A (en) 2022-04-27

Similar Documents

Publication Publication Date Title
CN107043378A (zh) 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
CA3013518C (en) Tlr7 agonist crystalline form a, preparation method and use thereof
US9540321B2 (en) Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate
CA3013521C (en) Trifluoroacetate salt of a pyrrolo[3,2-d]pyrimidin compound as tlr7 agonist and crystalline form b thereof
CA3013682C (en) Maleate salt of a pyrrolo[3,2-d]pyrimidine compound as tlr7 agonist and crystalline forms c, d and e thereof
CN103483273B (zh) 6-甲基-5-氟-2,4-嘧啶二胺类化合物及其制备与应用
WO2016110224A1 (zh) 玻玛西尼的制备方法
CN102746294B (zh) (s,s)-2,8-二氮杂双环【4.3.0】壬烷的制备方法
CN105985343A (zh) 伊布替尼的制备方法
WO2023125102A1 (zh) 1H-呋喃并[3,2-b]咪唑并[4,5-d]吡啶化合物的合成方法
HK1259183B (zh) 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
CN104592222A (zh) 抗血小板药物azd6482的制备方法
Jiang et al. Design, synthesis and cytotoxicity of novel 2-arylvinyl-4-aminoquinoline derivatives
CN120383608A (zh) 三环化合物的盐、其晶型及其应用
JP2025143418A (ja) ピリミジノ-ジアゼピン誘導体の調製のための方法
CN101429206A (zh) 六氢-1-硫代-3,4-二氮杂-环戊烷[cd]茚-4-酮及其合成方法
HK1259182B (zh) 一种tlr7激动剂的三氟乙酸盐、晶型b、制备方法和用途
HK1259170B (zh) 一种tlr7激动剂的晶型a、其制备方法和用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170815

WD01 Invention patent application deemed withdrawn after publication